Curta researchers are proud to introduce the Oncology Simulation Model (OSM), a novel model framework that combines and extends existing modeling practices into an innovative and dynamic simulation model to estimate prevalence and survival in oncology. This flexible framework can be leveraged to answer many research questions considering efficacy, treatment patterns, and sequencing.
The full text can be accessed in November’s Clinical Epidemiology https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673939/.